Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:07 pm Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Redmile Group LLC | 2,711,616 6.900% | 2,711,616 (New Position) | Filing History |
| 2021-02-12 4:32 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital LLC | 1,364,990 3.500% | -227,449 (-14.28%) | Filing History |
| 2021-02-12 09:52 am Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW INVESTMENTS LP | 3,422,855 8.660% | 1,537,855 (+81.58%) | Filing History |
| 2021-02-11 4:33 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,740,000 (Position Closed) | Filing History |
| 2021-02-11 07:39 am Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 6.320% | 600,000 (+31.58%) | Filing History |
| 2021-02-10 4:51 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RENAISSANCE TECHNOLOGIES LLC | 1,048,827 2.650% | -66,541 (-5.97%) | Filing History |
| 2020-10-22 12:27 pm Purchase | 2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX | Logos Global Management LP | 1,700,000 4.300% | 1,700,000 (New Position) | Filing History |
| 2020-07-24 4:05 pm Purchase | 2020-07-14 | 13G | Celldex Therapeutics, Inc. CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,900,000 5.010% | 1,900,000 (New Position) | Filing History |
| 2020-06-26 5:28 pm Purchase | 2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX | BIOTECHNOLOGY VALUE FUND L P | 2,740,000 7.200% | 2,740,000 (New Position) | Filing History |
| 2020-06-19 10:36 am Purchase | 2020-06-11 | 13G | Celldex Therapeutics, Inc. CLDX | RTW INVESTMENTS LP | 1,885,000 9.950% | 1,885,000 (New Position) | Filing History |
| 2020-06-18 09:11 am Purchase | 2020-06-10 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital LLC | 1,592,439 7.100% | 1,592,439 (New Position) | Filing History |